Catabasis Pharmaceuticals, Inc.
Get Full AccessDescription
- At Catabasis Pharmaceuticals, our mission is to bring hope and life-changing therapies to patients and their families. Our SMART (Safely Metabolized And Rationally Targeted) Linker drug discovery platform enables us to engineer molecules that simultaneously modulate multiple targets in a disease. We are applying our SMART LinkerSM platform to build an internal pipeline of product candidates for rare diseases and plan to pursue partnerships to develop additional product candidates. For more information on the Company's drug discovery platform and pipeline of drug candidates, please visit www.catabasis.com.
-
Headquarters:100 High Street , Boston, Massachusetts, United States
More -
Phone Number: +1 617-349-1971
-
Website: https://www.catabasis.com
-
Employees:45
-
Revenue:$50 - 100M
-
Legal Name:Catabasis Pharmaceuticals, Inc.
-
Catabasis Pharmaceuticals, Inc.'s Social Media
-
Is this data correct?
-
| NAICS Code: 446110 |
Show More
Frequently Asked Questions regarding Catabasis Pharmaceuticals, Inc.
-
Where are Catabasis Pharmaceuticals, Inc.'s Headquarters?
Catabasis Pharmaceuticals, Inc.'s Headquarters are in 100 High Street ,Boston,Massachusetts,United States
-
What is Catabasis Pharmaceuticals, Inc.'s phone number?
Catabasis Pharmaceuticals, Inc.'s phone number is +1 617-349-1971
-
What is Catabasis Pharmaceuticals, Inc.'s official website?
Catabasis Pharmaceuticals, Inc.'s official website is https://www.catabasis.com
-
What is Catabasis Pharmaceuticals, Inc.'s Revenue?
Catabasis Pharmaceuticals, Inc.'s revenue is $50 - 100M
-
What is Catabasis Pharmaceuticals, Inc.'s NAICS code?
Catabasis Pharmaceuticals, Inc.'s NAICS code is 446110
-
How many employees are working in Catabasis Pharmaceuticals, Inc.
Catabasis Pharmaceuticals, Inc. has 45 employees
-
What is Catabasis Pharmaceuticals, Inc.'s Industry?
Catabasis Pharmaceuticals, Inc. is in the industry of Biotechnology
-
Who is Catabasis Pharmaceuticals, Inc.'s CEO?
Catabasis Pharmaceuticals, Inc.'s CEO is Jill Milne

